載入中
NASDAQFinancial ServicesShell Companies
最新資料
US$10.75
−US$0.01 · -0.09%
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
前收盤價
US$10.75
−US$0.01 · -0.09%
盤中時間採用ET。市場資料可能有所延遲。
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
日內區間
目前US$10.75
52週區間
目前US$10.75
盤中時間採用ET。市場資料可能有所延遲。
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
日內區間
目前US$10.75
52週區間
目前US$10.75
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 |
|---|---|---|
| 銷售、一般及管理費用 | 119.57萬 USD | 703.61 USD |
| 營業費用 | 119.57萬 USD | 703.61 USD |
| 利息收入 | 848.45萬 USD | 158.87萬 USD |
| 折舊和攤銷 | — | 70.36萬 USD |
| 營業利益 | −119.57萬 USD | −703 USD |
| 淨利 | 728.88萬 USD | 2663 USD |
公司資料更新於 2026年10月12日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
